Latest News Releases From The Newsroom
Gilead Scraps HR-MDS Trial; FDA OKs Verrica's Molluscum Treatment
July 22nd, 2023
Gilead Sciences, Inc. (Nasdaq: GILD) announced the termination of the Phase 3 ENHANCE study evaluating magrolimab plus azacitidine as a first-line treatment for higher-risk myelodysplastic syndromes (HR-MDS) due to futility based on a planned analysi. Read more
Boeing Secures $393M+ Contract Modification; Key Upcoming Date for F5 and Ryanair
July 22nd, 2023
The Boeing Company (NYSE: BA) was awarded a substantial contract modification worth $393,091,720 for Apache AH-64E aircraft, alongside support services and equipment. The Army Contracting Command at Redstone Arsenal, Alabama, is responsible . Read more
Breaking: Booz Allen Hamilton Settles Civil Case for $377.5M
July 22nd, 2023
According to a regulatory filing with the SEC, Booz Allen Hamilton Holding Corporation (NYSE: BAH) has reached a significant settlement agreement with the U.S. Department of Justice (DOJ) and on behalf of the Defense Contract Management Agency to res. Read more
Mirati Therapeutics' KRAZATI Faces Setback; Comerica Q2 Earnings Beat
July 21st, 2023
Mirati Therapeutics, Inc. (Nasdaq: MRTX) faced a setback when the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on the Conditional Marketing Authorisation Application (MAA) for its dr. Read more
SEC Settlement Propels DWAC; Regions Financial Q2 Earnings Meet Estimates
July 21st, 2023
Shares of Digital World Acquisition Corp. (Nasdaq: DWAC) surged more than 15% after settling fraud charges with the SEC. The charges were related to material misrepresentations made in forms filed during DWAC's initial public offering and its planned. Read more
Evertec Reveals Upbeat Outlook; Hewlett Packard Secures $26.48M Contract
July 21st, 2023
Evertec, Inc. (NYSE: EVTC) and Sinqia have entered a definitive agreement for Evertec's acquisition of Sinqia, a prominent player in Brazil's financial services software market. The deal is set at a value of R$27.19 per share, with a potential daily . Read more
Breaking: Evelo Biosciences and Bio-Rad Agree on Sublease Termination and Surrender Deal
July 20th, 2023
According to a regulatory filing with the SEC, Evelo Biosciences, Inc. (Nasdaq: EVLO) has entered into a Sublease Termination and Surrender Agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO). The agreement terminates the Sublease, which provided E. Read more
SEC Charges Digital World SPAC for Material Misrepresentations to Investors
July 20th, 2023
FOR IMMEDIATE RELEASE 2023-135 Washington D.C. / CRWE PRESS RELEASE / July 20, 2023 - The Securities and Exchange Commission today announced settled fraud charges against Digital World Acquisition Corporation (DWAC), a special purpose . Read more
Pasithea Therapeutics Snubs Takeover Bid, OKs $4M Share Buyback Plan
July 20th, 2023
Pasithea Therapeutics Corp. (Nasdaq: KTTA) has authorized a $4.0 million share repurchase plan (through a tender offer), to buy approximately 5.7 million shares of its outstanding common stock at $0.70 per share. The company's executive officers a. Read more
Empowering Women and Countering Terrorism: Highlights of U.S.-Arab League Talks
July 20th, 2023
The United States and the Arab League successfully concluded talks in Washington, D.C., addressing critical issues including regional conflicts, climate change, women’s economic empowerment, and counterterrorism. The two parties reaffirmed thei. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
CSX, VinFast Auto, and Crown Castle's Earnings Preview
April 14th, 2024Earnings Spotlight: McCormick, TD SYNNEX, and GameStop Set to Report
March 23rd, 2024Upcoming Earnings: Adobe, Ulta Beauty, and Smartsheet Under the Lens
March 10th, 2024
Member Login